Furthermore, we found that CD4+ CTLs expressed C-X-C motif chemokine ligand 13 (CXCL13), a B cell chemoattractant, and physically interacted with activated B cells in tumor lesions. This evidence concerns the gene CXCL13 and neoplasm.